Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities


Since their invention in 1991, peptide nucleic acids (PNAs) have been used in a myriad of chemical and biological assays. More recently, peptide nucleic acids have also been demonstrated to hold great potential as therapeutic agents because of their physiological stability, affinity for target nucle...

Descripción completa

Detalles Bibliográficos
Autores principales: Quijano, Elias, Bahal, Raman, Ricciardi, Adele, Saltzman, W. Mark, Glazer, Peter M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: YJBM 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733847/
https://www.ncbi.nlm.nih.gov/pubmed/29259523
Descripción
Sumario:Since their invention in 1991, peptide nucleic acids (PNAs) have been used in a myriad of chemical and biological assays. More recently, peptide nucleic acids have also been demonstrated to hold great potential as therapeutic agents because of their physiological stability, affinity for target nucleic acids, and versatility. While recent modifications in their design have further improved their potency, their preclinical development has reached new heights due to their combination with recent advancements in drug delivery. This review focuses on recent advances in PNA therapeutic applications, in which chemical modifications are made to improve PNA function and nanoparticles are used to enhance PNA delivery.

Ejemplares similares